Cargando…
Anticoagulation in Very Old Patients with Atrial Fibrillation (AVOPA): A Descriptive Observational Study
BACKGROUND: In older patients with nonvalvular atrial fibrillation, oral anticoagulation is challenging, especially among very old patients. Even though positive effects of oral anticoagulation have been described in this age group (> 85 years), there is still a high rate of inappropriate dosing....
Autores principales: | Hupfer, Maximilian, Gosch, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605956/ https://www.ncbi.nlm.nih.gov/pubmed/34115332 http://dx.doi.org/10.1007/s40801-021-00263-6 |
Ejemplares similares
-
Anticoagulation for Atrial Fibrillation in the Very Elderly: Make or Break?
por: Makimoto, Hisaki
Publicado: (2022) -
Direct Oral Anticoagulants in Old and Frail Patients with Atrial Fibrillation: The Advantages of an Anticoagulation Service
por: Vedovati, Maria Cristina, et al.
Publicado: (2022) -
Patients’ Perspectives on Commencing Oral Anticoagulants in Atrial Fibrillation: An Exploratory Qualitative Descriptive Study
por: Gebreyohannes, Eyob Alemayehu, et al.
Publicado: (2023) -
Oral Anticoagulants in the Oldest Old with Recent Stroke and Atrial Fibrillation
por: Polymeris, Alexandros A., et al.
Publicado: (2021) -
Oral Anticoagulants in Very Elderly Nonvalvular Atrial Fibrillation Patients With High Bleeding Risks: ANAFIE Registry
por: Okumura, Ken, et al.
Publicado: (2022)